Marco E G V Cattaneo

15PUBLICATIONS
90CO-AUTHORS
Vision sciencePredictive and prognostic markersOptical technologyInnate immunityCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 13, 2026
Clinical and molecular features of PRCD-associated retinopathy.

|Jun 12, 2026
Development and Internal Validation of a Side-Specific Nomogram Integrating mpMRI and Biopsy Features to Guide Nerve-Sparing Decision Making in Prostate Cancer with Capsular Contact.

|Mar 08, 2026
The optical coherence tomography and microperimetry biomarker evaluation in patients with geographic atrophy (OMEGA) study: Geographic atrophy progression in fundus autofluorescence - OMEGA report 3.

Philippe Valmaggia, Georg Ansari, Nadja Inglin

|Mar 04, 2026
Acute interleukin-1β antagonism decreases systemic inflammation, increases GLP-1 release, and modulates insulin secretion in individuals with prediabetes.

Justus S Fischer, Matthias Hepprich, Marco Cattaneo

|Jul 17, 2025
Cost-Effectiveness of Drug-Coated Balloons in the Treatment of Coronary Small Vessel Disease: A Report From the BASKET-SMALL 2 Randomized Controlled Trial.

Marco E G V Cattaneo, Michael Coslovsky, Samuel J P Malkin

|May 27, 2025
Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial-the CanpHy study.

Matthias Hepprich, Justus Fischer, Marco Cattaneo

Pageof 3

Frequent Collaborators

3 joint publications

Raban V Jeger

3 joint publications

Matthias Hepprich

2 joint publications

Bruno Scheller

2 joint publications

Maciej Kwiatkowski